Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Chongqing
Clinical trial register · China

Clinical Trials in Chongqing, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19224 matching records held by the registry are in this view. Synced 11 Nov 2026, 03:17 UTC
19224
Studies in scope
all four open statuses
11811
Recruiting now
open to new participants
2030
Lead sponsors
across recruiting studies
Top sites
Guangzhou 6 Beijing 6 Shanghai 4 Fuzhou 4 Changsha 3
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca107 Merck Sharp & Dohme LLC39 Janssen Research & Development, LLC39 First Affiliated Hospital of Chongqing Medical University34 Daping Hospital and the Research Institute of Surgery of the Third Military Medical University32 Eli Lilly and Company29 Chia Tai Tianqing Pharmaceutical Group Co., Ltd.25 The Second Affiliated Hospital of Chongqing Medical University22 Bristol-Myers Squibb18 BeOne Medicines18 Chongqing University Cancer Hospital18 Hoffmann-La Roche15 Beijing InnoCare Pharma Tech Co., Ltd.14 Pfizer14 Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.14 GlaxoSmithKline12 Xinqiao Hospital of Chongqing12 Chongqing Medical University11 Amgen11 Sanofi10 Dong Peng10 Third Military Medical University9 Ausper Biopharma Co., Ltd.9 Sichuan Baili Pharmaceutical Co., Ltd.9 Southwest Hospital, China8 Daiichi Sankyo8 Sun Yat-sen University8 Boehringer Ingelheim7 BioNTech SE7 Novartis Pharmaceuticals7 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.7 Gilead Sciences7 Takeda7 AbbVie7 Children's Hospital of Chongqing Medical University6 Shanghai Henlius Biotech6 MediLink Therapeutics (Suzhou) Co., Ltd.6 Dizal Pharmaceuticals6 RemeGen Co., Ltd.6 Biotheus Inc.6 Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.6 Jiangsu HengRui Medicine Co., Ltd.5 Peking University People's Hospital5 Abbisko Therapeutics Co, Ltd5 Novo Nordisk A/S5 UCB Biopharma SRL5 West China Hospital5 Second Affiliated Hospital, Zhejiang University, School of Medicine5 Fudan University5 Beijing Tiantan Hospital5 Nanfang Hospital, Southern Medical University5 Qifu Li5 Hutchmed5 Innovent Biologics (Suzhou) Co. Ltd.5 BeiGene4 Min Su4 ShiCang Yu4 DualityBio Inc.4 Tongji Hospital4 Institute of Medical Biology, Chinese Academy of Medical Sciences4 Peking University First Hospital4 Karuna Therapeutics, Inc., a Bristol Myers Squibb company3 Jiangsu Simcere Pharmaceutical Co., Ltd.3 Juventas Cell Therapy Ltd.3 TJ Biopharma Co., Ltd.3 Institute of Hematology & Blood Diseases Hospital, China3 Juan Kang3 Mirati Therapeutics Inc.3 Akeso3 Huashan Hospital3 Bio-Thera Solutions3 Chen Li3 Shandong Suncadia Medicine Co., Ltd.3 PharmaEssentia3 Alexion Pharmaceuticals, Inc.3 Astellas Pharma Global Development, Inc.3 Ascentage Pharma Group Inc.3 ArriVent BioPharma, Inc.3 Tang-Du Hospital3 Peking Union Medical College Hospital3 Xiamen Amoytop Biotech Co., Ltd.3 Mingzhao Xiao3 Nanjing Leads Biolabs Co.,Ltd3 Chongqing Precision Biotech Co., Ltd2 Klus Pharma Inc.2 Sichuan University2 Green Valley (Shanghai) Pharmaceuticals Co., Ltd.2 Three Gorges Hospital of Chongqing University2 Innostellar Biotherapeutics Co.,Ltd2 Suzhou Suncadia Biopharmaceuticals Co., Ltd.2 Beijing QL Biopharmaceutical Co.,Ltd2 Children's Hospital of Fudan University2 Grit Biotechnology2 JHM BioPharma (Tonghua) Co. , Ltd.2 Tasly Pharmaceutical Group Co., Ltd2 Brise Pharmaceuticals Co., Ltd.2 Teligene US2 Xiaolong Li2 Shanghai Jiao Tong University School of Medicine2 Air Force Military Medical University, China2 Eikon Therapeutics2 Acerta Pharma BV2 Lepu Medical Technology (Beijing) Co., Ltd.2 Dingqun Bai2 Celgene2 Guangzhou Lupeng Pharmaceutical Company LTD.2 Yunfeng Xia2 Cancer Institute and Hospital, Chinese Academy of Medical Sciences2 argenx2 Epygenix2 First Hospital of China Medical University2 Chinese Academy of Medical Sciences, Fuwai Hospital2 First Affiliated Hospital of Zhejiang University2 Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.2 Nanjing RegeneCore Biotech Co., Ltd.2 Hangzhou Sumgen Biotech Co., Ltd.2 Hansoh BioMedical R&D Company2 Loxo Oncology, Inc.2 CanSino Biologics Inc.2 Jie Chen2 Evopoint Biosciences Inc.2 Biogen2 The Affiliated Hospital of Qingdao University2 Chongqing Normal University2 Beijing Tsinghua Chang Gung Hospital2 Zhejiang University2 Lepu Biopharma Co., Ltd.2 Aragon Pharmaceuticals, Inc.2 Yuehui Yin2 Allist Pharmaceuticals, Inc.1 Second Xiangya Hospital of Central South University1 Shandong First Medical University1 Ipsen1 Beijing Children's Hospital1 Shanghai Auzone Biological Technology Co., Ltd.1 Harbin Medical University1 Shanghai AbelZeta Ltd.1 Antengene Therapeutics Limited1 Simcere Pharmaceutical Co., Ltd1 fan li1 Pierre Fabre Medicament1 Incyte Corporation1 Shanghai Hongdian Medical CO., LTD1 Beijing Pins Medical Co., Ltd1 Central China Fuwai Hospital of Zhengzhou University1 The Children's Hospital of Zhejiang University School of Medicine1 Union Hospital, Tongji Medical College, Huazhong University of Science and Technology1 The First Affiliated Hospital of Shihezi University1 Chongqing Peg-Bio Biopharm Co., Ltd.1 Shanghai Argo Biopharmaceutical Co., Ltd.1 Shanghai Escugen Biotechnology Co., Ltd1 958th Army Hospital of the Chinese People's Liberation Army1 Hangzhou PhecdaMed Co., Ltd.1 Boston Intelligent Medical Research Center, Shenzhen United Scheme Technology Co., Ltd.1 Acerand Therapeutics (Shanghai) Limited1 Changhai Hospital1 Viatris Innovation GmbH1 Aligos Therapeutics1 University of Siena1 Qilu Pharmaceutical Co., Ltd.1 The Affiliated Hospital Of Guizhou Medical University1 GeneCradle Inc1 Army Medical Center of PLA1 Nuvation Bio Inc.1 Xiu Huang1 VivaVision Biotech, Inc1 DK Medical Technology (Suzhou) Co., Ltd.1 CARsgen Therapeutics Co., Ltd.1 Min Long1 Shanghai Huilun Pharmaceutical Co., Ltd.1 Sichuan Enray Pharmaceutical Sciences Company1 Kunming Pharmaceuticals, Inc.1 Vantive Health LLC1 Cytokinetics1 FrontAce Scientific Co., Ltd1 Avenzo Therapeutics, Inc.1 Suzhou Immunofoco Biotechnology Co., Ltd1 Xintian Pharmaceutical1 Laekna Limited1 Waterstone Pharmaceutical (Wuhan) Co., LTD.1 Sinocare1 Hinova Pharmaceuticals Inc.1 Wei Zhou1 TCRCure Biopharma Ltd.1 Kylonova (Xiamen) Biopharma co., LTD.1 Medtronic Neurovascular Clinical Affairs1 Staidson (Beijing) Biopharmaceuticals Co., Ltd1 Inventiva Pharma1 SPH Sine Pharmaceutical Laboratories Co., Ltd.1 The University of Hong Kong1 Transcenta Therapeutics (Hangzhou) Co., Ltd.1 InSilico Medicine Hong Kong Limited1 Shenzhen Majory Biotechnology Co., Ltd.1 Hangzhou Gensciences Biopharmaceutical Co., Ltd.1 Dermavon Holdings Limited1 Chinese PLA General Hospital1 Haisco Pharmaceutical Group Co., Ltd.1 Eisai Co., Ltd.1 Xueqin Yang1 Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.1 Suzhou Puhe Pharmaceutical Technology Co., LTD1 SPH Qingdao Growful Pharmacetical Co.,Ltd1 The First Affiliated Hospital with Nanjing Medical University1 shifeng Lou1 Shanghai Pulmonary Hospital, Shanghai, China1 Actelion1 Sellas Life Sciences Group1 Ningbo Newbay Technology Development Co., Ltd1 Chinese SLE Treatment And Research Group1 First Affiliated Hospital of Wenzhou Medical University1 Zenith Epigenetics1 Dongying Zhang1 Shenyang Sunshine Pharmaceutical Co., LTD.1 Hangzhou GluBio Pharmaceutical Co., Ltd.1 Chongqing Jinsaixing Medical Technology Co., Ltd1 Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine1 Capital Medical University1 Nanjing IASO Biotechnology Co., Ltd.1 Sunshine Lake Pharma Co., Ltd.1 Guangdong Provincial People's Hospital1 Peking Union Medical College1 Chen Xiangmei1 Eye & ENT Hospital of Fudan University1 The First Affiliated Hospital of Soochow University1 Army Medical University, China1 Ocumension Therapeutics (Suzhou) Co., Ltd1 Geneplus-Beijing Co. Ltd.1 Sinovac Biotech Co., Ltd1 Alpha Biopharma (Jiangsu) Co., Ltd.1 Xuanqi Yang1 InnoCare Pharma Inc.1 Qilu Hospital of Shandong University1 Jilin University1 Mingjian Ge1 GeneQuantum Healthcare (Suzhou) Co., Ltd.1 Bayer1 Zai Lab (Shanghai) Co., Ltd.1 3D Medicines (Sichuan) Co., Ltd.1 Mabwell (Shanghai) Bioscience Co., Ltd.1 Sound Biopharmaceuticals Ltd.1 Peking University Third Hospital1 Genor Biopharma Co., Ltd.1 Permed Biomedical Engineering Co., Ltd1 Shanghai Jiaolian Drug Research and Development Co., Ltd1 Xinyu Zhou1 You Lu1 Shanghai Haiyan Pharmaceutical Technology Co., Ltd.1 Hua Huang, MD, PhD1 Chongqing Claruvis Pharmaceutical Co., Ltd.1 Huahui Health1 Beijing Anzhen Hospital1 SyMap Medical (Suzhou), Ltd.1 Boston Scientific Corporation1 Changchun GeneScience Pharmaceutical Co., Ltd.1 Chengdu New Radiomedicine Technology Co. LTD.1 Tavotek Biotherapeutics1 Alpine Immune Sciences Inc, A Subsidiary of Vertex1 MSD R&D (China) Co., Ltd.1 Nanjing Medical University1 Chongqing General Hospital1 Biotech Pharmaceutical Co., Ltd.1 Liu yong1 Chengdu Qingshan Likang Pharmaceutical Co., Ltd1 Jiangsu Carephar Pharmaceutical Co., Ltd.1 Salubris Biotherapeutics Inc1 Resonova (Shanghai) Medtech Limited1 Binhui Biopharmaceutical Co., Ltd.1 Nanjing First Hospital, Nanjing Medical University1 Guangzhou Virotech Pharmaceutical Co., Ltd.1 The Third Affiliated Hospital of Guangzhou Medical University1 Bellus Health Inc. - a GSK company1 Cascade Pharmaceuticals, Inc1 Hangzhou DAC Biotechnology Co., Ltd.1 Newish Biotech (Wuxi) Co., Ltd.1 Chinese Academy of Medical Sciences1 Yongquan Shi1 CLASSYS Inc.1 Regeneron Pharmaceuticals1 Genmab1 Zhang Tao1 Genovn Therapeutics (Suzhou) Co., Ltd.1 Alnylam Pharmaceuticals1 The First Affiliated Hospital of Anhui Medical University1 Shanghai Bomaian Medical Technology Co., Ltd1 ImmuneOnco Biopharmaceuticals (Shanghai) Inc.1 NGGT (Suzhou) Biotechnology Co., Ltd.1 Shanghai Zhongshan Hospital1 BioDlink Biopharm Co., Ltd.1 Vor Biopharma1 Haihe Biopharma Co., Ltd.1 AriBio Co., Ltd.1 Zhejiang Yangli Pharmaceutical Technology Co., Ltd.1 Shanghai Junshi Bioscience Co., Ltd.1 Gang Chen1 Longhao Li1 Sinovac (Dalian) Vaccine Technology Co., Ltd.1 Shumin Yang1 Sichuan Provincial People's Hospital1 Xu Yan1 Guangdong Association of Clinical Trials1 Medtronic Spinal and Biologics1 Nanjing Minova Pharmaceutical Co., Ltd.1 Longhua Hospital1 Beijing Continent Pharmaceutical Co, Ltd.1 Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences1 Mundipharma (China) Pharmaceutical Co. Ltd1 Xing Liu1 Beijing Hospital of Traditional Chinese Medicine1 CStone Pharmaceuticals1 BrosMed Medical Co., Ltd1 Jing Huang1 Xin Fan1 Shanghai Mianyi Biopharmaceutical Co., Ltd.1 Clear sponsor filter
Target enrolment
to

Trials with a site in Chongqing

2 of 19224 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Active, closed
argenx
Phase 3
141
Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou, Jinan, Nanchang, Shanghai
2024-09-18
Active, closed
argenx
Phase 3
119
Beijing, Changchun, Chongqing, Fuzhou, Guangxi, Guangzhou, Guiyang, Ningbo
2024-04-16
Rows per page Showing 1–2 of 2
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 11 November 2026. https://priyalifescience.com/clinical-trials-china/city/chongqing

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,224 studies in total at the last sync on 11 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 2 of those studies with a site in Chongqing that also match the filters currently applied.

How many clinical trials are recruiting in Chongqing?

0 of the 2 studies on this page are recruiting new participants as of the 11 Nov 2026, 03:17 UTC sync. A further 0 have not yet opened recruitment, 2 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Chongqing), 2 studies
PhaseStudiesRecruitingShare
Phase 320100%

Most active sponsors

Lead sponsors with the most studies (Chongqing)
Lead sponsorStudiesRecruiting
argenx20
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.